Pharmacogenomic Study (Adjuvant Chemotherapy)
Conditions
Gastric Cancer
Conditions: official terms
Stomach Neoplasms
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
To assess the role of germline polymorphisms in xenobiotic metabolism genes in toxicity profile.

To assess the role of germline polymorphisms in genes associated with DNA repair, p53 tumor suppressor gene and angiogenesis pathway in predicting recurrence and survival in gastric cancer patients treated with adjuvant chemotherapy.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- gastric cancer patients treated with adjuvant chemotherapy

Exclusion Criteria:
Location
Samsung Medical Center
Seoul, Korea, Republic of
Status: Recruiting
Contact: mi yeon kwon, RN - +82-2-3410-1248 - miyeon.kwon@samsung.com
Start Date
July 2008
Sponsors
Samsung Medical Center
Source
Samsung Medical Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page